| |
| |
|
| Insider
Information: |
Pearce Samantha |
| Relationship: |
SVP, Head of Europe & ... |
| City: |
Dublin 4 |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
16,922 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,849,067 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
16,922 |
|
|
| Total
Value |
$1,849,067 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Jazz Pharmaceuticals Inc |
JAZZ |
SVP, Head of Europe & ... |
2024-03-05 |
16,922 |
2020-05-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2024-03-05 |
4 |
D |
$117.53 |
$290,769 |
D/D |
(2,474) |
16,922 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,065 |
19,396 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2024-01-17 |
4 |
D |
$119.13 |
$123,657 |
D/D |
(1,038) |
14,331 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2024-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,210 |
15,369 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2023-03-05 |
4 |
D |
$142.78 |
$288,416 |
D/D |
(2,020) |
13,159 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2023-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,870 |
15,179 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2023-02-02 |
4 |
OE |
$109.45 |
$58,118 |
D/D |
531 |
11,840 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2023-02-02 |
4 |
AS |
$157.26 |
$83,505 |
D/D |
(531) |
11,309 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2023-01-03 |
4 |
AS |
$159.59 |
$84,742 |
D/D |
(531) |
11,309 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2023-01-03 |
4 |
OE |
$109.45 |
$58,118 |
D/D |
531 |
11,840 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-12-13 |
4 |
AS |
$155.45 |
$82,544 |
D/D |
(531) |
11,309 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-12-13 |
4 |
OE |
$109.45 |
$58,118 |
D/D |
531 |
11,840 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-11-10 |
4 |
AS |
$155.00 |
$164,765 |
D/D |
(1,063) |
11,309 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-11-10 |
4 |
OE |
$109.45 |
$116,345 |
D/D |
1,063 |
11,840 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-09-02 |
4 |
AS |
$156.98 |
$83,356 |
D/D |
(531) |
11,309 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-09-02 |
4 |
OE |
$109.45 |
$58,118 |
D/D |
531 |
11,840 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-08-04 |
4 |
AS |
$155.00 |
$82,305 |
D/D |
(531) |
11,309 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-08-04 |
4 |
OE |
$109.45 |
$58,118 |
D/D |
531 |
11,840 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-07-12 |
4 |
AS |
$155.00 |
$82,460 |
D/D |
(532) |
11,309 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-07-12 |
4 |
OE |
$109.45 |
$58,227 |
D/D |
532 |
11,841 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-06-27 |
4 |
AS |
$155.00 |
$1,318,740 |
D/D |
(8,508) |
11,309 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-06-27 |
4 |
OE |
$109.45 |
$931,201 |
D/D |
8,508 |
19,817 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-06-08 |
4 |
OE |
$109.45 |
$638,641 |
D/D |
5,835 |
19,796 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Internat |
• – – |
2022-06-08 |
4 |
AS |
$155.00 |
$1,315,485 |
D/D |
(8,487) |
11,309 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Head of Europe & Interna |
• – – |
2022-03-05 |
4 |
D |
$153.96 |
$282,671 |
D/D |
(1,836) |
13,961 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
